Hostname: page-component-7c8c6479df-hgkh8 Total loading time: 0 Render date: 2024-03-28T20:58:17.225Z Has data issue: false hasContentIssue false

The role of oestrogen replacement in the climacteric syndrome

Published online by Cambridge University Press:  09 July 2009

Rudi Borth*
Affiliation:
From the Departments of Obstetrics and Gynaecology and of Psychology, St Michael's Hospital, University of Toronto, Canada
Ronald C. Strickler
Affiliation:
From the Departments of Obstetrics and Gynaecology and of Psychology, St Michael's Hospital, University of Toronto, Canada
Anthony Cecutti
Affiliation:
From the Departments of Obstetrics and Gynaecology and of Psychology, St Michael's Hospital, University of Toronto, Canada
Brian A. Cookson
Affiliation:
From the Departments of Obstetrics and Gynaecology and of Psychology, St Michael's Hospital, University of Toronto, Canada
John A. Harper
Affiliation:
From the Departments of Obstetrics and Gynaecology and of Psychology, St Michael's Hospital, University of Toronto, Canada
Robert Potvin
Affiliation:
From the Departments of Obstetrics and Gynaecology and of Psychology, St Michael's Hospital, University of Toronto, Canada
Paul Riffel
Affiliation:
From the Departments of Obstetrics and Gynaecology and of Psychology, St Michael's Hospital, University of Toronto, Canada
V. James Sorbara
Affiliation:
From the Departments of Obstetrics and Gynaecology and of Psychology, St Michael's Hospital, University of Toronto, Canada
C. Allan Woolever
Affiliation:
From the Departments of Obstetrics and Gynaecology and of Psychology, St Michael's Hospital, University of Toronto, Canada
*
1Address for correspondence: Dr Rudi Borth, Department of Obstetrics and Gynaecology, St Michael's Hospital, 30 Bond Street, Toronto, Ontario, Canada M5B 1W8.

Synopsis

Using a double-blind placebo-controlled cross-over design, the effect of equine conjugated oestrogens tablets (Premarin®) was studied in 20 women with the climacteric syndrome followed during 15 months. Sixteen women were equally improved on placebo and oestrogen. Only 2 patients had an improved sense of well-being on oestrogen and not on placebo. The psychological diagnosis was unrelated to the subjective response to oestrogen or placebo. Performance in psychological tests administered before and during treatment periods was not changed by oestrogen or placebo.

Type
Research Article
Copyright
Copyright © Cambridge University Press 1977

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Burt, R. L., Haskins, A. & Leventhal, M. L. (1969). Management of climacteric and postmenopausal women. In Controversy in Obstetrics and Gynecology (ed. Reid, D. E. and Barton, T. C.), pp. 327350. W. B. Saunders: Toronto.Google Scholar
Carter, W. F., Faucher, G. L. & Greenblatt, R. B. (1964). Evaluation of a new progestational agent, 6, 17αdimethyl 6-dehydroprogesterone. American Journal of Obstetrics and Gynecology 89, 635641.CrossRefGoogle Scholar
Chabon, I. (1973). The menopause and oestrogen therapy. Journal of Reproductive Medicine 11, 233278.Google Scholar
Clayden, J. R., Bell, J. W. & Pollard, P. (1974). Menopausal flushing: double-blind trial of a non-hormonal medication. British Medical Journal i, 409412.CrossRefGoogle Scholar
Coope, J., Thompson, J. M. & Poller, L. (1975). Effects of ‘natural oestrogen’ replacement therapy on menopausal symptoms and blood clotting. British Medical Journal iv, 139142.CrossRefGoogle Scholar
George, G. C. W., Utian, W. H. & Beumont, P. J. V. (1973). Effect of exogenous oestrogens on minor psychiatric symptoms in postmenopausal women. South African Medical Journal 47, 23872388.Google ScholarPubMed
Hathway, S. P. & McKinley, J. C. (1942). A multiphasic personality schedule: I. Construction of the schedule. Journal of Psychology 10, 249254.CrossRefGoogle Scholar
Kantor, H. I., Michael, C. M. & Shore, H. (1973). Estrogen for older women. American Journal of Obstetrics and Gynecology 116, 115118.CrossRefGoogle ScholarPubMed
Kupperman, H. S. (1972). A guide to diagnosis and management of the menopause and postmenopause. Ayerst Laboratories: New York.Google Scholar
Kupperman, H. S., Wetchler, B. B. & Blatt, M. G. (1959). Contemporary therapy of the menopausal syndrome. Journal of the American Medical Assocation 171, 16271637.CrossRefGoogle ScholarPubMed
Lancet (1975). Editorial: Eternal youth, i, 12821283.Google Scholar
Mulley, G. & Mitchell, J. R. A. (1976). Menopausal flushing: does oestrogen therapy make sense? Lancet i, 13971399.CrossRefGoogle Scholar
Pratt, J. P. & Thomas, W. L. (1937). The endocrine treatment of menopausal phenomenon. Journal of the American Medical Association 109, 18751880.CrossRefGoogle Scholar
Rakoff, A. E. (1975). Female climacteric: premenopause, menopause, post-menopause. In Gynecologic Endocrinology (ed. Gold, J. J.), pp. 356376. Harper and Row: Hagers-town, Md.Google Scholar
Ryan, K. J. (1973). Menopause and Aging. DHEW Publication (NIH) No. 73–319: Bethesda, Md.Google Scholar
Sarason, I. G. (1966). Personality: an Objective Approach. John Wiley & Sons: New York.Google Scholar
Utian, W. H. (1972). The mental tonic effect of oestrogensadministered to oophorectomized females. South African Medical Journal 46, 10791082.Google ScholarPubMed
Wilson, R. A. & Wilson, T. A. (1963). The fate of the non-treated post-menopausal woman: a plea for the maintenance of adequate oestrogen from puberty to the grave. Journal of the American Geriatrics Society 11, 347362.CrossRefGoogle Scholar
Winer, B.J. (1962). Statistical Principles in Experimental Design. McGraw-Hill: New York.CrossRefGoogle Scholar